Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CategoryEquity - Leveraged / Inverse Asset TypeEquities (Stocks) TagsU.S. Return% 1Y40.28% Shs Outstand Perf Week-4.14%
SponsorDirexion Shares ETF Type Tagsequity Return% 3Y-16.81% Total Holdings51 Perf Month-19.36%
Fund Family Bond Type Tagspharmaceutical Return% 5Y-14.05% AUM13.23M Perf Quarter7.90%
IndexS&P Pharmaceuticals Sel Industry Indx Average Maturity Tagsmedical Return% 10Y NAV% Perf Half Y27.57%
Index Weighting Commodity Type Tagsleverage Return% SI NAV/sh Perf Year35.89%
Active/Passive Quant Type Tags- Flows% 1M-3.30% 52W Range5.76 - 10.62 Perf YTD7.48%
Dividend TTM0.12 (1.39%) ESG Type Tags- Flows% 3M-20.51% 52W High-21.56% Beta2.20
Dividend Ex-DateSep 24, 2024 Dividend Type Sector/Theme Flows% YTD-21.08% 52W Low44.62% ATR (14)0.35
Expense0.95% Structure Type Region Flows% 1Y RSI (14)42.05 Volatility3.31% 4.17%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.49 Prev Close8.31
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume47.92K Price8.33
SMA20-4.29% SMA50-6.29% SMA2008.40% Trades Volume71,472 Change0.24%
Mar-23-22 07:49AM
Jun-22-20 01:00PM
Feb-10-20 09:39AM
Jan-20-20 11:55AM
Jan-16-20 10:28AM
12:51PM Loading…
Jan-10-20 12:51PM
Nov-04-19 08:00AM
Nov-01-19 10:10AM
Aug-28-19 11:08AM
Jul-14-19 11:00AM
Jun-04-19 11:37AM
May-31-19 06:18PM
May-23-19 01:27PM
Apr-09-19 02:14PM
Feb-25-19 11:56AM
04:39PM Loading…
Jan-10-19 04:39PM
Jul-30-18 11:39AM
Jul-27-18 01:54PM
01:38PM
Jul-12-18 03:51PM
Jun-04-18 10:05AM
Nov-29-17 05:03PM
02:06PM
Nov-22-17 08:00AM
Nov-15-17 02:07PM
09:00AM
Feb-28-17 05:22PM
Feb-27-17 12:23PM
Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.